What is the intrinsic value of PATH?
As of 2025-10-29, the Intrinsic Value of Uipath Inc (PATH) is
0.19 USD. This PATH valuation is based on the model Peter Lynch Fair Value.
With the current market price of 16.16 USD, the upside of Uipath Inc is
-98.82%.
Is PATH undervalued or overvalued?
Based on its market price of 16.16 USD and our intrinsic valuation, Uipath Inc (PATH) is overvalued by 98.82%.
PATH Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(11.08) - (4.61) |
(6.59) |
-140.8% |
| DCF (Growth 10y) |
(6.59) - (14.79) |
(9.11) |
-156.4% |
| DCF (EBITDA 5y) |
(3.17) - (4.68) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(4.48) - (6.36) |
(1,234.50) |
-123450.0% |
| Fair Value |
0.19 - 0.19 |
0.19 |
-98.82% |
| P/E |
1.57 - 1.96 |
1.78 |
-89.0% |
| EV/EBITDA |
1.05 - 1.03 |
1.05 |
-93.5% |
| EPV |
(1.95) - (2.68) |
(2.32) |
-114.3% |
| DDM - Stable |
0.22 - 0.55 |
0.39 |
-97.6% |
| DDM - Multi |
(0.47) - (0.93) |
(0.63) |
-103.9% |
PATH Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
8,581.28 |
| Beta |
1.04 |
| Outstanding shares (mil) |
531.02 |
| Enterprise Value (mil) |
7,952.67 |
| Market risk premium |
4.60% |
| Cost of Equity |
13.12% |
| Cost of Debt |
5.00% |
| WACC |
8.97% |